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Dynein Arms, Cause Primary Ciliary Dyskinesia
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Primary ciliary dyskinesia (PCD) is a group of autosomal-recessive disorders resulting from cilia and sperm-flagella defects, which lead to
respiratory infections and male infertility. Most implicated genes encode structural proteins that participate in the composition of
axonemal components, such as dynein arms (DAs), that are essential for ciliary and flagellar movements; they explain the pathology
in fewer than half of the affected individuals. We undertook this study to further understand the pathogenesis of PCD due to the absence
of both DAs. We identified, via homozygosity mapping, an early frameshift in LRRC6, a gene that encodes a leucine-rich-repeat (LRR)-
containing protein. Subsequent analyses of this gene mainly expressed in testis and respiratory cells identified biallelic mutations in
several independent individuals. The situs inversus observed in two of them supports a key role for LRRC6 in embryonic nodal cilia.
Study of native LRRC6 in airway epithelial cells revealed that it localizes to the cytoplasm and within cilia, whereas it is absent from cells
with loss-of-function mutations, in which DA protein markers are also missing. These results are consistent with the transmission-elec-
tron-microscopy data showing the absence of both DAs in cilia or flagella from individuals with LRRC6mutations. In spite of structural
and functional similarities between LRRC6 andDNAAF1, another LRR-containing protein involved in the same PCDphenotype, the two
proteins are not redundant. The evolutionarily conserved LRRC6, therefore, emerges as an additional player in DA assembly, a process
that is essential for proper axoneme building and that appears to be much more complex than was previously thought.Primary ciliary dyskinesia (PCD [MIM 244400]) is a hetero-
geneous group of genetic disorders affecting 1 in 15,000–
30,000 individuals and is usually transmitted as an auto-
somal-recessive trait.1 This disease results from structural
and functional defects of cilia and leads to impaired muco-
ciliary transport responsible for early recurrent respiratory-
tract infections. Approximately 50% of individuals with
PCD display situs inversus, which defines Kartagener syn-
drome (MIM 244400).2 Moreover, most male individuals
are infertile as a result of functional and ultrastructural
abnormalities in sperm flagella, whose axonemal structure
is similar to that of motile cilia.3
The axoneme, the core of motile cilia and flagella,
consists of nine peripheral microtubule doublets and
a central complex composed of two single microtubules.
Attached to the peripheral doublets, the inner and outer
dynein arms (IDAs and ODAs, respectively) are multipro-
tein ATPase complexes that are essential for normal ciliary
and flagellar movements.4 Various axonemal ultrastruc-
tural defects have been reported in PCD, and most of
them concern ODAs and/or IDAs.5 A second level of
heterogeneity in PCD is attested to by the fact that the
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encode structural proteins that participate in the composi-
tion of diverse axonemal components.6,7 The identifica-
tion of other mutations has revealed the importance of
some genes in the proper assembly of ciliary axonemes:
CCDC398 (MIM 613807) and CCDC409 (MIM 613808)
mutations are implicated in individuals with axonemal
disorganization and an absence of IDAs. Mutations in
RPGR (MIM 300455), a gene that was first involved in non-
syndromic retinitis pigmentosa and that encodes a protein
implicated in intraflagellar transport, have been found in
a PCD phenotype characterized by a complex ultrastruc-
tural respiratory-cilia defect associated with retinitis pig-
mentosa.6 As for PCD cases due to the absence of both
dynein arms (DAs), mutations in genes involved in cyto-
plasmic preassembly of DAs, such as DNAAF2 (previously
KTU [MIM 612518]),10 DNAAF1 (previously LRRC50
[MIM 613193]),11,12 and DNAAF3 (MIM 606763), have
been identified.13 Just recently, a fourth gene called
CCDC103 (MIM 614679) and believed to play a role in
anchoring DAs to microtubules has been associated
with this phenotype.14 However, although the absence
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present in at least one-third of PCD cases,5 mutations in
those genes account for only a small proportion of cases:
DNAAF1 mutations explain 17% of PCD cases with an
absence of both DAs;11 DNAAF2 mutations have been re-
ported in only two unrelated families;10 and DNAAF3
and CCDC103 have been found to be mutated in three
and six families, respectively.13,14
We undertook this study in order to identify additional
genes involved in the PCD phenotype characterized by
the absence of both DAs. Forty-seven unrelated families
(containing 50 affected individuals) of our cohort have
PCD and/or male sterility with an absence of both DAs.
In all of them, the axonemal defect was confirmed by
transmission electron microscopy (TEM) showing a lack
of ODAs and IDAs on all microtubule doublets of all exam-
ined cilia and/or spermatozoa. By screening the genes
already known to be involved in this phenotype, we iden-
tified mutations in only seven families: DNAAF1 muta-
tions in six families (Duquesnoy et al.11 and unpublished
data) and DNAAF2 mutations in one family (unpublished
data). DNAAF3 has so far not been found to be involved in
our cohort, whereas the very recently identified CCDC103
remains to be analyzed. Among the 42 individuals (31
males and 11 females) belonging to the remaining 40
families, 37 had a PCD diagnosis with typical clinical
features (sinopulmonary syndrome beginning in early
childhood; this was associated with situs inversus in 17
of them). The remaining five persons (from five unrelated
families) were included because their male sterility with
immotile sperm flagella was related to an absence of
both DAs (documented by TEM); three of them also pre-
sented with minor respiratory problems (bronchorrhea
and nasal obstruction). Infertility was noted in a total of
15 adults (13 males and 2 females). Seven individuals
were born to a consanguineous union; one of these
families (DC28) had two affected siblings (DCP16 and
DCP17). The current study was approved by the Ile-de-
France ethics committee (CPP07729), and written in-
formed consent was obtained from all individuals and/or
their parents.
Genomic DNAs from the seven individuals of the six
consanguineous families were first analyzed by means
of homozygosity mapping. A large homozygous region
identified in chromosomal region 8q24.22, spanning
4,852,130 bp between rs6997983 and rs7825610, was
found to be shared by the two affected siblings of
family DC28 (Figure S1A, available online). This region
contains 20 genes (Figure S1B), including leucine-rich-
repeat (LRR)-containing 6 (LRRC6), which several argu-
ments prompted us to consider as an excellent candidate
for PCD. As reported in a previous proteomic study,15 it
is expressed in the flagella of Chlamydomonas reinhardtii
and in human cilia. In mice, Lrrc6 transcripts have been
found to be expressed in tissues that have flagella or motile
cilia.16,17 In addition, a putative PCD locus containing
LRRC6 has been identified in a genome-wide linkage study
performed in familial cases of PCD.18 Most importantly,The Americanthe phenotypic features of several animal models with
mutations in LRRC6 orthologs are consistent with ciliary
defects. In zebrafish, seahorse mutants display a curved
body with pronephric cysts,19 associated with left-right
abnormalities in half cases.20 In Drosophila, a null allele
of the LRRC6 ortholog, called tilB, is responsible for ciliary
dysfunction of sensory neurons of the auditory organ and
male sterility.21
In humans, LRRC6 consists of 12 exons; the only pre-
dicted transcript (RefSeq accession number NM_012472.3)
encodes a 466 residue protein with five N-terminal LRR
motifs (Figure 1A). The LRR repeats of LRRC6 (Figure 1B)
contain the consensus sequence LxxLxLxxNxIxxIxxLxzx
Lxx (‘‘z’’ indicates frequent deletions), which defines the
SDS22-like subfamily of LRR-containing proteins.22 Each
LRR repeat is a b-strand-turn-a-helix structure, and all to-
gether, thesemotifs are known to form a solenoid (repeated
structural units that form a continuous superhelix).23
LRRC6 also contains an LRRcap that shields the solenoid,
a coiled-coil (CC)domain, apolylysinemotif, andaC-termi-
nal a-crystallin-p23-like domain.
With the aim of testing the implication of LRRC6 in
PCD, we first determined its expression by quantitative
RT-PCR. The analysis revealed that LRRC6 is mainly ex-
pressed in the testis, as well as in respiratory epithelial cells
obtained from nasal brushing; this expression pattern is
typical of cilia-associated genes (Figure S2A). Consistent
with this, LRRC6 expression levels in those tissues were
found to be similar to those of DNAAF1, DNAAF2,
DNAAF3, and CCDC103 (Figure S2B). We subsequently
screened LRRC6 for mutations in individual DCP16 from
family DC28. Sequence-variant databases, such as dbSNP,
Ensembl, and the National Heart, Lung, and Blood Insti-
tute (NHLBI) Exome Variant Server (EVS), were used for
filtering out previously identified SNPs. This analysis iden-
tified homozygous frameshift mutation c.598_599delAA
(in exon 5), leading to a premature stop codon at position
202 (p.Lys200Glufs*3). The same homozygous mutation
was also present in her affected brother (DCP17). Their
asymptomatic mother was found to harbor the mutation
in the heterozygous state (Figure S3), and paternal DNA
was not available. We subsequently screened for LRRC6
mutations in the remaining 39 independent families (40
individuals) affected by the absence of both DAs. Four
of them (DC21, DC108, DC1039, and DC1026) had bial-
lelic LRRC6 mutations, consistent with a loss of function
of the corresponding protein (Figure 1A and Figure S3).
Individual DCP18 (family DC21) had two premature
stop codons in exon 5: the c.574C>T (p.Gln192*)
nonsense mutation on one allele and the frameshift
c.576dupA (p.Glu193Argfs*4) mutation on the other, as
shown by the sequencing of cloned PCR products. Indi-
vidual DCP152 (family DC108) was also shown to be
homozygous for the c.598_599delAA (p.Lys200Glufs*3)
mutation identified in family DC28. His asymptomatic
mother had the mutation in the heterozygous state,
and paternal DNA was not available. Individual DCP193Journal of Human Genetics 91, 958–964, November 2, 2012 959
Figure 1. LRRC6 Mutations and Their
Impact at the Protein Level in Individuals
with PCD
(A) Exonic organization of the human
LRRC6 cDNA, in which are shown the
mutations (top) and domain-organiza-
tion model of the corresponding protein
(middle). The mutations’ impact at the
protein level is shown for the five families
described in this study (bottom). The
twelve exons are indicated by empty or
hashed boxes, depicting translated or
untranslated sequences, respectively. Ac-
cording to the LRRC6 domain-organiza-
tion model, derived from predictions by
NCBI and UniProt/Swiss-Prot, the protein
contains four LRR domains (amino acids
23–42, 46–65, 68–87, and 90–112), one
modified LRR domain (amino acids 115–
130) and a subsequent LRRcap (amino
acids 131–146), a coiled-coil domain
(amino acids 178–204), a polylysine motif
(amino acids 272–286), and an a-crystal-
lin-p23-like domain (amino acids 332–
381).
(B) A partial protein alignment of LRRC6
shows the evolutionary conservation of
the third LRR motif and the LRRcap
domain, which contains the two amino
acid substitutions identified in this study.(family DC1039) had a homozygous transversion in exon
3: c.220G>C (p.Ala74Pro). Homozygosity and consan-
guinity were confirmed in DCP152 and DCP193 by
whole-genome genotyping with the Human CytoSNP-12
chip from Illumina (data not shown). Individual DCP339
(family DC1026) was a compound heterozygote and had
the frameshift c.598_599delAA (p.Lys200Glufs*3, exon 5)
mutation on one allele and a transversion (c.436G>C in
exon 5) introducing a missense variation (p.Asp146His)
on the other allele, as demonstrated by the sequencing
of cloned PCR products. If translated, the p.Gln192*,
p.Glu193Argfs*4, and p.Lys200Glufs*3 molecular defects
are predicted to result in severely truncated proteins lack-
ing more than half of the protein, including the polylysine
motif and the a-crystallin-p23-like domain (Figure 1A).
The p.Ala74Pro amino acid substitution, which replaces
an amino acid of low steric hindrance with a cyclic amino
acid, involves a residue that is invariant throughout evolu-
tion and that belongs to the third LRR motif of LRRC6.
Proline is a breaker of a helices and b strands, so the
p.Ala74Pro substitution is expected to disrupt this motif.
The p.Asp146His (c.436G>C) amino acid substitution
lies in the LRRcap, an LRR-associated motif commonly
found in members of the SDS22-like subfamily of LRR-
containing proteins. This motif is defined by the
consensus sequence YRxx4xxx4Px4xxLD (Figure 1B), in
which ‘‘4’’ represents any hydrophobic residue. The first
and last amino acids (tyrosine and aspartic acid, respec-
tively) of the LRRcap are hydrogen bonded24 and shield
the LRR superhelix. The p.Asp146His amino acid substitu-
tion, which involves a residue that is highly conserved960 The American Journal of Human Genetics 91, 958–964, Novembthroughout evolution (Figure 1B), most likely has a detri-
mental effect on LRRC6 conformation.
With the aim of assessing the effect of this mutation on
LRRC6 conformation, we used the resolution structure of
the closest crystallized protein, the Chlamydomonas ODA
LC1 dynein light chain (structure ID 1DS9). Asp180 (the
equivalent of Asp146 in human LRRC6) and Tyr165 (the
equivalent of Tyr131 in human LRRC6) form a hydrogen
bond. The p.Asp180His variation replaces an acidic amino
acid with a noncharged residue containing an imidazole
functional group; the formation of a hydrogen bond
with Tyr165 would considerably increase the free energy
of this molecule (from 2,843 kJ/mol to þ1,126 kJ/mol,
Figure S4), a result incompatible with the existence of
such a structure.
Overall, we identified LRRC6 mutations in six individ-
uals from five families. LRRC6 was therefore found to be
mutated in 10.6% (5/47) of the families affected by a
PCD phenotype characterized by an absence of both
DAs. The nonsense and frameshift mutations, as well
as the c.220G>C missense mutation, are not reported in
databases such as dbSNP, Ensembl, or EVS. As for the
c.436G>C missense variation, it is not described in En-
sembl; however, it has just recently been reported in
dbSNP (rs200321595; no allele frequency is available)
and in EVS at an extremely low frequency (3 of 13,004
alleles; allele frequency ¼ 0.00023), so the homozygous
genotype is expected to be extremely rare. Given that the
incidence of PCD ranges from 1 in 15,000 to 1 in 30,000
affected individuals, the expected frequency of a PCD
allele ranges from 0.006 to 0.008. Therefore, such a lower 2, 2012
Table 1. Phenotypic Features of Individuals with Identified LRRC6 Mutations
Family
(Origin) Individual
Known
Consanguinity Gender
Situs
Inversus Airway Disease Fertility
CBF
(Hz) Allele 1 Allele 2
DC28
(European)
DCP16 yes female no NRD, bronchitis,
bronchiectasis,
lobectomy,
rhinosinusitis, otitis
hypofertility 0 c.598_599delAA
(p.Lys200Glufs*3)
c.598_599delAA
(p.Lys200Glufs*3)
DCP17 yes male yes bronchitis,
rhinosinusitis
asthenospermia 0 c.598_599delAA
(p.Lys200Glufs*3)
c.598_599delAA
(p.Lys200Glufs*3)
DC21
(European)
DCP18a no male no bronchitis,
bronchiectasis,
rhinosinusitis, nasal
polyposis
asthenospermia 0 c.574C>T
(p.Gln192*)
c.576dupA
(p.Glu193Argfs*4)
DC108
(European)
DCP152 no male no bronchitis,
bronchiectasis,
rhinosinusitis, otitis
NR 0 c.598_599delAA
(p.Lys200Glufs*3)
c.598_599delAA
(p.Lys200Glufs*3)
DC1039
(European)
DCP193 no male no bronchorrhea asthenospermia 0 c.220G>C
(p.Ala74Pro)
c.220G>C
(p.Ala74Pro)
DC1026
(European)
DCP339 no male yes bronchitis,
bronchiectasis,
rhinosinusitis, otitis
asthenospermia ND c.598_599delAA
(p.Lys200Glufs*3)
c.436G>C
(p.Asp146His)
The following abbreviations are used: CBF, ciliary beat frequency; NRD, neonatal respiratory distress; NR, not relevant; and ND, not determined.
aVery low nasal nitric-oxide levels (13 nl/min) were documented in this individual.allele frequency for the c.436G>Cmutation, together with
the fact that this missense mutation was identified in trans
to a frameshift, is consistent with the implication of the
c.436G>C allele in the disease. The c.598_599delAA muta-
tion is shared by three families (DC28, DC108, and
DC1026) not known to be related (Table 1). Genotyping
of microsatellites markers that flank LRRC6 (D8S1765,
D8S558, and D8S1740) and span ~1.9 Mb of the disease
locus supports a founder effect (Figure S5).
Several conclusions can be drawn from the analysis
of the PCD phenotype of individuals with LRRC6 muta-
tions (Table 1). Four individuals (DCP16, DCP17, DCP18,
and DCP152) who have biallelic nonsense or frameshift
mutations display a typical disease phenotype: their cilia
are immotile (Movies S1 and S2). Another individual
(DCP339), who also has a typical disease phenotype, har-
bors the c.598_599delAA frameshift mutation in combina-
tion with the c.436G>C missense mutation that, at the
protein level, is expected to severely impair protein func-
tion by conformational change. The only individual with
moderate respiratory symptoms is DCP193, who is also
the only one with partial absence of both DAs in airway
cilia (Figure 2). Noteworthy is that this individual is also
the only one who has a homozygous missense mutation
(c.220G>C). This suggests that the p.Ala74Pro amino
acid substitution would be compatible with the produc-
tion of a partially functional protein and would thereby
lead to a milder phenotype. The situs inversus observed
in two individuals (DCP17 and DCP339) supports a key
role for LRRC6 in the proper functioning of embryonic
nodal cilia. These phenotype-genotype correlations also
show that, like in individuals with DNAAF1 or DNAAF2
mutations (Duquesnoy et al.11 and our unpublished
data), all adult individuals (four males and one female)The Americanwithmutations in LRRC6 have fertility problems. In males,
as shown in Figure 2, infertility is readily explained by the
absence of both DAs in sperm flagella.
To gain further insight into the role of LRRC6, we deter-
mined its subcellular localization in human ciliated cells
by means of high-resolution immunofluorescence micros-
copy. This was performed in ciliated cells collected by nasal
brushing25 from both a control individual and individual
DCP18 with the LRRC6 c.[574C>T; 576dupA] genotype.
In ciliated cells from a control individual, strong LRRC6
labeling was observed in the cytoplasm and within the
cilia (Figures 3A–3C). By contrast, LRRC6 was not detected
in airway epithelial cells from individual DCP18 (Figures
3D–3F). This latter result, which confirms the specificity
of the labeling obtained with the LRRC6 antibody used
in these experiments, is consistent with the loss-of-func-
tion mutations identified in this individual. Immuno-
staining of the ODA intermediate chain DNAI2 (Figures
3H and 3K) and of the IDA component DNALI1 (Figures
3N and 3Q) indicates that the loss of LRRC6 in ciliated
cells affects the assembly of DAs; these results confirm
the TEM data clearly showing the absence of ODAs and
IDAs in cilia or flagella from individuals with LRRC6muta-
tions (Figure 2).
All together, these data raise the larger question of the
mechanism by which the loss of function of LRRC6 results
in the absence of DAs in cilia and flagella. One possible
answer relies on the striking similarities between LRRC6
and DNAAF1, a gene that has been shown to play a key
role in cytoplasmic preassembly of DAs.11 Mutations in
LRRC6 and DNAAF1 result in molecular defects that
have the same impact on ciliary ultrastructure. These two
genes have a similar expression pattern—high expression
levels in ciliated tissues—especially in nasal brushingsJournal of Human Genetics 91, 958–964, November 2, 2012 961
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Figure 3. LRRC6 Localizes to the Cytoplasm and Cilia and Is
Absent in DCP18
(A–F) In control cells, LRRC6 (green) localizes to the cytoplasm
and within cilia, whereas it is absent from the individual’s cells.
Axoneme-specific antibodies directed against a-b-tubulin were
used as a control. Nuclei were stained with DAPI (blue).
Similar experiments were performed with antibodies directed
against the ODA component DNAI2 (G–L) and the IDA compo-
nent DNALI1 (M–R). In control cells, DNAI2 and DNALI1 localize
within the cilia, whereas labeling is absent from the individual’s
cells. Airway epithelial cells were examined after labeling with
a mouse LRRC6 antibody (Abnova) and a secondary goat anti-
mouse Alexa Fluor-488 (green) antibody (Invitrogen). For controls,
we used antibodies directed against various axonemal compo-
nents: a-b-tubulin (Cell Signaling Technology), DNAI2 (Abnova),
and DNALI1 (Abnova) for the visualization of microtubules,
ODAs, and IDAs, respectively; primary antibodies were revealed
with a secondary Alexa Fluor-594 (red) or Alexa Fluor-488 (green)
antibody (Invitrogen). White scale bars represent 5 mm.
Figure 2. Absence of Both DAs in Respiratory Cilia and/or Sper-
matozoa Flagella of Individuals with LRRC6 Mutations
The electron micrographs of cross-sections of cilia and/or sperma-
tozoa flagella from a control and individuals with identified LRRC6
mutations are shown. The blue flashes and triangles show the
presence of ODAs and IDAs, respectively, and red flashes and trian-
gles show their absence in affected individuals’ axonemes. Note
the partial absence of DAs in the airway cilia of DCP193 (blue
flash), whereas at the sperm level, the absence of DAs seems
complete. Black scale bars represent 0.1 mm.(Figure S2B). The corresponding proteins are both mainly
localized within the cytoplasm of respiratory epithelial
cells, and strikingly, they share similar domains: an LRR
solenoid shielded by an LRRcap followed by a coiled-coil
domain. The data suggest that LRRC6 is an additional
player in cytoplasmic preassembly of DAs but that, in spite
of its structure and functional similarities with DNAAF1,
the two proteins are not redundant. Additional possible
clues in the physiological role of LRRC6 come from the
fact that LRRC6 and its Drosophila ortholog, TilB, share
an a-crystallin-p23-like domain. Proteins with an a-crystal-
lin domain belong to the family of small heat-shock
proteins, HSPB, and it has been suggested that HSPB
members can act as cytoskeleton-specific chaperones.26
These data are of particular interest in light of a recently
proposed model for preassembly of DAs.13 This model
hypothesizes that oda7, pf13, and pf22 (the orthologs of
DNAAF1, DNAAF2, and DNAAF3, respectively), which
are proteins required for the recognition and proper fold-
ing of the dynein-heavy chains present in Chlamydomonas
reinhardtii ODAs, work within a chaperone complex.13
It has been shown that ODA7 interacts with both
ODAs and IDAs27 and that loss of function in one of
those three proteins results in the absence of both DAs
in humans.10,11,13 Although the precise process whereby
LRRC6 is involved in preassembly and/or transport of
DAs remains to be clarified, it is therefore tempting to spec-962 The American Journal of Human Genetics 91, 958–964, Novembulate that LRRC6 is a part of this chaperone complex by
acting via its a-crystallin-p23-like domain in this elabo-
rated mechanism of DA preassembly.er 2, 2012
In summary, this study shows that, similarly to muta-
tions in DNAAF1, DNAAF2, DNAAF3, and CCDC103,
mutations in LRRC6 result in the most frequent type of
PCD phenotype (i.e., absence of both DAs). Overall,
among the 47 families affected by an absence of both
DAs in our cohort, 12 have mutations in one of those
genes. The current model for cytoplasmic preassembly of
DAs involves four actors: DNAAF1, DNAAF2, DNAAF3,
and a chaperone complex in which LRRC6, on the basis
of its predicted domain organization, is likely to partici-
pate. Given that no molecular defect has yet been identi-
fied for several individuals with an absence of both DAs,
it is likely that other genes contribute to the disease.
Identification of those genes should help in better defining
the molecular mechanisms involved in DA assembly, a
process that is essential for proper axoneme building and
that appears to be much more complex than was previ-
ously thought.Supplemental Data
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